Pressure Biosciences Stock Gross Profit
Pressure Biosciences fundamentals help investors to digest information that contributes to Pressure Biosciences' financial success or failures. It also enables traders to predict the movement of Pressure OTC Stock. The fundamental analysis module provides a way to measure Pressure Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pressure Biosciences otc stock.
Pressure |
Pressure Biosciences OTC Stock Gross Profit Analysis
Pressure Biosciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Pressure Biosciences Gross Profit | 1.06 M |
Most of Pressure Biosciences' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pressure Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Pressure Biosciences reported 1.06 M of gross profit. This is 99.95% lower than that of the Life Sciences Tools & Services sector and 99.93% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Pressure Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pressure Biosciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pressure Biosciences could also be used in its relative valuation, which is a method of valuing Pressure Biosciences by comparing valuation metrics of similar companies.Pressure Biosciences is currently under evaluation in gross profit category among its peers.
Pressure Fundamentals
Return On Asset | -0.93 | ||||
Operating Margin | (3.18) % | ||||
Current Valuation | 33.23 M | ||||
Shares Outstanding | 11.07 M | ||||
Shares Owned By Insiders | 1.27 % | ||||
Shares Owned By Institutions | 0.05 % | ||||
Number Of Shares Shorted | 6.34 K | ||||
Price To Earning | (1.05) X | ||||
Price To Sales | 9.95 X | ||||
Revenue | 2 M | ||||
Gross Profit | 1.06 M | ||||
EBITDA | (5.59 M) | ||||
Net Income | (20.15 M) | ||||
Cash And Equivalents | 121.57 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 150 K | ||||
Debt To Equity | 2.04 % | ||||
Current Ratio | 0.07 X | ||||
Book Value Per Share | (2.44) X | ||||
Cash Flow From Operations | (4.87 M) | ||||
Short Ratio | 3.00 X | ||||
Earnings Per Share | (2.59) X | ||||
Target Price | 1.57 | ||||
Number Of Employees | 12 | ||||
Beta | 0.73 | ||||
Market Capitalization | 23.22 M | ||||
Total Asset | 2.83 M | ||||
Retained Earnings | (81.02 M) | ||||
Working Capital | 9.2 M | ||||
Current Asset | 13.07 M | ||||
Current Liabilities | 3.88 M | ||||
Z Score | 53.5 | ||||
Net Asset | 2.83 M |
Pair Trading with Pressure Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pressure Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Ford could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ford when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ford - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ford Motor to buy it.
The correlation of Ford is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ford moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ford Motor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ford can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |